Clinical trials: Extended Spectrum Beta-Lactamase Producing Bacteria Infection
Antimicrobial Drug Resistance, Antibiotic Resistant Infection
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
The goal of this observational study is to investigate how bacterial populations from the intestine and mouth of patients change during the hospitalization period and evaluate if some populations of specific bacteria increase or…
- Conditions
- Antimicrobial Drug Resistance, Antibiotic Resistant Infection, Clostridium Difficile, Carbapenem-Resistant Enterobacteriaceae Infection
- Trial name
- DYNAMITE (NCT06258551)
- Where
- 2 sites in United States
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- The Methodist Hospital Research Institute
Extended Spectrum Beta-Lactamase Producing Bacteria Infection, Microbial Colonization
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
Antimicrobial resistance is a major threat worldwide and extended-spectrum beta-lactamase producing Enterobacteriales (ESBL-E) are a leading cause because of their wide dissemination.
- Conditions
- Extended Spectrum Beta-Lactamase Producing Bacteria Infection, Microbial Colonization, Critical Illness
- Trial name
- Microbe (NCT04131569)
- Testing
- ESBL-E fecal carriage screening according to routine care
- Where
- France
- Volunteers
- 60 people
- Sponsor
- University of Bordeaux